The present invention relates to the use of a filamentous bacteriophage, wriich displays an antibody that specifically binds to a pro-inflammatory cytokine, either alone or in combination with a filamentous bacteriophage that does not display a mammalian cell internalization signal, to treat Parkinson"s disease.